Please login to the form below

Not currently logged in
Email:
Password:

Ipsos

This page shows the latest Ipsos news and features for those working in and with pharma, biotech and healthcare.

Ipsos set to buy GfK Research divisions

Ipsos set to buy GfK Research divisions

Ipsos set to buy GfK Research divisions. Acquires customer experience, experience innovation, health and public affairs. ... GfK’s innovation arm, which incorporates research in car clinics, VR technology, user experience research, design and consulting

Latest news

  • The state of trust The state of trust

    Summing up the study’s findings, Ipsos MORI’s chief executive officer Ben Page concluded: “People are massively wrong about lots of things.”. ... He then detailed an experiment Ipsos MORI carried out about communicating a medical diagnosis and

  • Lilly joins Personal Connected Health Alliance Lilly joins Personal Connected Health Alliance

    Lilly joins Personal Connected Health Alliance. Samsung, AT&T and IPSOS Healthcare also sign up. ... Alongside the pharma firm the PCH Alliance has also welcomed the likes of Samsung AT&T and IPSOS Healthcare.

  • The Digital Patient The Digital Patient

    An Ipsos Healthcare survey last year revealed that around half of respondents in the US and UK said they would use a connected health device or tool if it was recommended

  • Ipsos forms connected health partnership Ipsos forms connected health partnership

    Ipsos forms connected health partnership. Joins forces with Arizona State University company HoneyB Health. ... Ipsos Healthcare is the global healthcare division of Ipsos, the world's third largest market research company.

  • Kitchener’s Moustache and the Importance of Contextualisation Kitchener’s Moustache and the Importance of Contextualisation

    A couple more questions for you to ponder:. How much do you agree with the viewpoint of Didier Truchot CEO at Ipsos, as expressed in a recent ESOMAR article, that market

More from news
Approximately 2 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Trust me, I’m from pharma Trust me, I’m from pharma

    Individual companies are doing their bit too. For example, in September 2017, Roche commissioned Ipsos/MORI research that showed the UK public trusts supermarkets more than they do drug firms.

  • The real-world data conundrum The real-world data conundrum

    However, a comprehensive study (by Ipsos Mori and the Wellcome Trust in 2016) has shown that most of the general public tend to accept commercial sharing of health data and acknowledge

  • Harnessing complexity Harnessing complexity

    head of global MDx portfolio, Ipsos Healthcare. 5th February 2016.

  • Help or harm? How do Doctors really feel about digital health? Help or harm? How do Doctors really feel about digital health?

    Tracking the physician perspective. The Ipsos Healthcare Digital Doctor tracker aims to keep abreast of the physician activity and perception on digital health. ... After all, without deviation from the norm, progress is impossible. The Ipsos Healthcare

  • Choices, choices: the rapidly evolving HIV treatment landscape Choices, choices: the rapidly evolving HIV treatment landscape

    Ipsos' HIV Therapy Monitor data shows that the top reason for prescribing an STR is convenience. ... Samantha Fernando PhD and Amy Butterworth are part of Ipsos Healthcare's Virology Therapy Monitor team.

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics